Skip to content

IMR Assessment in Patients With New Diagnosis of Left Ventricle Dilatation

Index of Microcirculatory Resistance (IMR) Assessment in Patients With New Diagnosis of Left Ventricular Dilatation Without Significant Coronary Artery Lesions: IMPAIRED Pilot Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02705170
Acronym
IMPAIRED
Enrollment
35
Registered
2016-03-10
Start date
2016-03-31
Completion date
2018-04-30
Last updated
2018-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathies, Microcirculation, Microvessels

Keywords

index of microvascular resistance

Brief summary

To establish if, in patients with new diagnosis of left ventricular dilatation without documentation at the coronary artery angiography of significant coronary artery lesions, there is a damage of the coronary microcirculation at the IMR (index of microcirculatory resistance) assessment

Detailed description

The Authors will enroll at the moment of coronary artery angiography patients without history of ischemic heart disease and new diagnosis (at transthoracic echocardiography) of left ventricular dilation. All patients will undergo coronary artery angiography. To be enrolled, it is necessary to have the absence of significant coronary artery stenosis (angiographic evaluation of the lesion \>40%) in all the vessels (main and side branch). The Authors will proceed to perform the evaluation of the index of microvascular resistance (IMR). The target vessel will be the left anterior descending artery. An intracoronary pressure/temperature sensor-tipped guidewire will be used. Thermodilution curves will be obtained during maximal hyperemia. The IMR will be calculated from the ratio of the mean distal coronary pressure at maximal hyperemia to the inverse of mean hyperemic transit time.

Interventions

Measurement of the index of microvascular resistance in the left anterior descending artery

Sponsors

University Hospital of Ferrara
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* new diagnosis of left ventricular dilation (dilatative cardiopathy) * absence of significant (\>40%) coronary artery disease at coronary artery angiography

Exclusion criteria

* history of ischemic heart disease * history of significant valvular disease * contraindication to hyperemic agent

Design outcomes

Primary

MeasureTime frameDescription
Index of microcirculatory resistanceduring coronary artery angiographyMeasurement of IMR in the left anterior descending artery of patients with new diagnosis of left ventricular dilatation and no significant stenosis in epicardial coronary arteries

Secondary

MeasureTime frameDescription
cardiac death1-yearoccurrence of cardiac death at 1 year

Other

MeasureTime frameDescription
all-cause death1-yearoccurrence of all-cause death at 1 year
heart failure1-yearoccurrence of hospital admission for heart failure

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026